A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
Public ClinicalTrials.gov record NCT04064827. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Prospective, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Paricalcitol Oral Solution for the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects Ages 0 to 9 Years With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Study identification
- NCT ID
- NCT04064827
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 2 participants
Conditions and interventions
Interventions
- Paricalcitol Drug
Drug
Eligibility (public fields only)
- Age range
- 0 Years to 9 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 15, 2020
- Primary completion
- Jun 8, 2025
- Completion
- Jun 8, 2025
- Last update posted
- Dec 3, 2025
2020 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital /ID# 225417 | Little Rock | Arkansas | 72202 | — |
| Stanford University School of Medicine - Redwood City /ID# 252150 | Redwood City | California | 94063 | — |
| Childrens National Medical Center /ID# 225991 | Washington D.C. | District of Columbia | 20010-2916 | — |
| Holtz Childrens Hospital, University of Miami /ID# 225636 | Miami | Florida | 33136-1005 | — |
| Nicklaus Children's Hospital /ID# 210517 | Miami | Florida | 33155-3009 | — |
| Emory University /ID# 140665 | Atlanta | Georgia | 30322-1014 | — |
| Augusta University Medical Center /ID# 252149 | Augusta | Georgia | 30912-0004 | — |
| Boston Children's Hospital /ID# 162863 | Boston | Massachusetts | 02115 | — |
| Duplicate_Levine Children's Specialty Center- Charlotte /ID# 216057 | Charlotte | North Carolina | 28203-5866 | — |
| Atrium Health Wake Forest Baptist Medical Center /ID# 266045 | Winston-Salem | North Carolina | 27157 | — |
| Children's Hospital of Philadelphia - Main /ID# 213802 | Philadelphia | Pennsylvania | 19104-4319 | — |
| University of Texas Southwestern Medical Center /ID# 210495 | Dallas | Texas | 75390-7208 | — |
| University of Utah /ID# 140669 | Salt Lake City | Utah | 84112-5500 | — |
| Seattle Children's Hospital /ID# 162861 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04064827, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2025 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04064827 live on ClinicalTrials.gov.